anonymous
Guest
anonymous
Guest
Your CEO is going to reach $800M!!!
This last two posts are comical, if not moronic.
Intentionally keeping the stock price down prevents Acorda from making any strategic acquisition. It is frozen and fully dependent on the Approval of Inbrija.
Perhaps the Market has not realized the value of Inbrija, or suitors remain at the sidelines scare of another Complete Response Letter??? Whatever it is, if Leadership doesn't act to increase the price of the stock, the investor pool (Scopia included) will get quite nervous, either bail-out or demand a Sale.
Ron, as a daily reader of Cafepharma, you need to "do something", other than waiting this one out. Surely, Hindman is pushing you to act, while Wasman screams caution. A strategic acquisition is a must, if you plan to realize the dreams of another Regeneron. Otherwise, merge Acorda into another company that will be a better steward of the assets.
anonymous
Guest
anonymous
Guest
This last two posts are comical, if not moronic.
Intentionally keeping the stock price down prevents Acorda from making any strategic acquisition. It is frozen and fully dependent on the Approval of Inbrija.
Perhaps the Market has not realized the value of Inbrija, or suitors remain at the sidelines scare of another Complete Response Letter??? Whatever it is, if Leadership doesn't act to increase the price of the stock, the investor pool (Scopia included) will get quite nervous, either bail-out or demand a Sale.
Ron, as a daily reader of Cafepharma, you need to "do something", other than waiting this one out. Surely, Hindman is pushing you to act, while Wasman screams caution. A strategic acquisition is a must, if you plan to realize the dreams of another Regeneron. Otherwise, merge Acorda into another company that will be a better steward of the assets.
I believe both posts were sarcasm. Ron being strategic and Inbrija hitting $800M. Funny stuff!
anonymous
Guest
anonymous
Guest
Yes we have a plan and Scopia is onboard. Trust your Leadership.This last two posts are comical, if not moronic.
Intentionally keeping the stock price down prevents Acorda from making any strategic acquisition. It is frozen and fully dependent on the Approval of Inbrija.
Perhaps the Market has not realized the value of Inbrija, or suitors remain at the sidelines scare of another Complete Response Letter??? Whatever it is, if Leadership doesn't act to increase the price of the stock, the investor pool (Scopia included) will get quite nervous, either bail-out or demand a Sale.
Ron, as a daily reader of Cafepharma, you need to "do something", other than waiting this one out. Surely, Hindman is pushing you to act, while Wasman screams caution. A strategic acquisition is a must, if you plan to realize the dreams of another Regeneron. Otherwise, merge Acorda into another company that will be a better steward of the assets.
anonymous
Guest
anonymous
Guest
This last two posts are comical, if not moronic.
Intentionally keeping the stock price down prevents Acorda from making any strategic acquisition. It is frozen and fully dependent on the Approval of Inbrija.
Perhaps the Market has not realized the value of Inbrija, or suitors remain at the sidelines scare of another Complete Response Letter??? Whatever it is, if Leadership doesn't act to increase the price of the stock, the investor pool (Scopia included) will get quite nervous, either bail-out or demand a Sale.
The above post was not intended as sarcasm!!!!
Ron, as a daily reader of Cafepharma, you need to "do something", other than waiting this one out. Surely, Hindman is pushing you to act, while Wasman screams caution. A strategic acquisition is a must, if you plan to realize the dreams of another Regeneron. Otherwise, merge Acorda into another company that will be a better steward of the assets.
anonymous
Guest
anonymous
Guest
Your CEO is indeed a strategic brilliant thinker. 800 is well within reach. Our early sales team preoccupied training docs on how to administer Inbrija. When we get approval sales will explode !I believe both posts were sarcasm. Ron being strategic and Inbrija hitting $800M. Funny stuff!
anonymous
Guest
anonymous
Guest
Your CEO is indeed a strategic brilliant thinker. 800 is well within reach. Our early sales team preoccupied training docs on how to administer Inbrija. When we get approval sales will explode !
Good stuff! “Your” CEO, “our” sales team. Honey, you can’t even keep your shit straight. You might want to make sure your “sales” team isn’t doing anything with this prior to approval other than familiarizing themselves with offices or you might be in even more shit than you bargained for.
Here’s to the strategy “inhale your way to fewer off periods” accompanied by “superiority data? Trust us!”
$325M. GoGoGo!
anonymous
Guest
anonymous
Guest
Your Leadership Team will deliver. 325 M unacceptable as we can do much better. Your grammatical correction aside, your CEO is at work right now! 800Mis goal.Good stuff! “Your” CEO, “our” sales team. Honey, you can’t even keep your shit straight. You might want to make sure your “sales” team isn’t doing anything with this prior to approval other than familiarizing themselves with offices or you might be in even more shit than you bargained for.
Here’s to the strategy “inhale your way to fewer off periods” accompanied by “superiority data? Trust us!”
$325M. GoGoGo!
anonymous
Guest
anonymous
Guest
Is the "beacon" you are referring to that tiny light that your proctologist shines up the your hole when looking at your hemorrhoids?
If you have none, then wait until we at Sunovion are done with you, Acorda and that levodopa e-cigarette.
Hope your insurance covers proctology service. You are going to need them
If you have none, then wait until we at Sunovion are done with you, Acorda and that levodopa e-cigarette.
Hope your insurance covers proctology service. You are going to need them
anonymous
Guest
anonymous
Guest
Is the "beacon" you are referring to that tiny light that your proctologist shines up the your hole when looking at your hemorrhoids?
If you have none, then wait until we at Sunovion are done with you, Acorda and that levodopa e-cigarette.
Hope your insurance covers proctology service. You are going to need them
another post by a competitor...just ignore ...they hate our success ! we will show them when we clean up with the FDA approval maybe in August !
anonymous
Guest
anonymous
Guest
another post by a competitor...just ignore ...they hate our success ! we will show them when we clean up with the FDA approval maybe in August !
Yeah that’s what it is.
Accordas only “success” was nearly 10 years ago.
Since then it’s been a comedy of errors, blanketed by egotistical and narcissistic musings.
Maybe people are simply tired of your overinflated sense of self given the multitude of f-ups.
Your like the kid in little league that critiques everyone and then strikes out when it’s his turn at bat.
$325M. GoGoGo!
anonymous
Guest
anonymous
Guest
Yeah that’s what it is.
Accordas only “success” was nearly 10 years ago.
Since then it’s been a comedy of errors, blanketed by egotistical and narcissistic musings.
Maybe people are simply tired of your overinflated sense of self given the multitude of f-ups.
Your like the kid in little league that critiques everyone and then strikes out when it’s his turn at bat.
$325M. GoGoGo!
LMAO ! LMAO !!! Amusing fictional depiction
What comedy of errors?? We did an A-1 job since our inception !!
You don't understand the challenges of business ups and downs; nor the issues Leadership has
with the rank & file.
We have winners in the pipeline so be patient and, if you actually work for us, DO YOUR JOB !!!!!!
anonymous
Guest
anonymous
Guest
Yeah that’s what it is.
Accordas only “success” was nearly 10 years ago.
Since then it’s been a comedy of errors, blanketed by egotistical and narcissistic musings.
Maybe people are simply tired of your overinflated sense of self given the multitude of f-ups.
Your like the kid in little league that critiques everyone and then strikes out when it’s his turn at bat.
$325M. GoGoGo!
Wasn't the "comedy-of-errors" due to unsupervised interns running into walls at the Regulatory Department?
They remind us of our folk hero, Humpty Dumpty
https://m.youtube.com/watch?v=nrv495corBc
Let's not blame our fantastic Leadership.
They truly know how to make omelettes out of broken eggs. Humpty wishes it had Ron and Lauren in his corner. The story will have been quite different.
Happy Easter y'all
;-)
anonymous
Guest
anonymous
Guest
LMAO ! LMAO !!! Amusing fictional depiction
What comedy of errors?? We did an A-1 job since our inception !!
You don't understand the challenges of business ups and downs; nor the issues Leadership has
with the rank & file.
We have winners in the pipeline so be patient and, if you actually work for us, DO YOUR JOB !!!!!!
Ahh the blaming continues. Perhaps if “leadership” has so many issues with the rank and file, they really aren’t competent leaders now are they?
Based on performance and stock price, it would appear your beloved “leaders” may have underestimated business ups and downs themselves.
But hey, there is always the magical world of Twitter where RC can look the part.
anonymous
Guest
anonymous
Guest
Wasn't the "comedy-of-errors" due to unsupervised interns running into walls at the Regulatory Department?
They remind us of our folk hero, Humpty Dumpty
https://m.youtube.com/watch?v=nrv495corBc
Let's not blame our fantastic Leadership.
They truly know how to make omelettes out of broken eggs. Humpty wishes it had Ron and Lauren in his corner. The story will have been quite different.
Happy Easter y'all
;-)
Lets put that intern fiasco behind us. Yes it was a comedy of errors and will NEVER happen again.
But Leadership has a strategic plan and is executing it to perfection. Look to a bright future.
Happy Passover and Easter to everyone !!